Impact of the implementation of a rapid meningitis/encephalitis multiplex polymerase chain reaction panel on IV acyclovir duration: multicenter, retrospective cohort of adult and pediatric patients
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The standard for diagnosing meningoencephalitis includes cerebrospinal fluid (CSF) culture and viral polymerase chain reaction (PCR). Approval of the FilmArray® BioFire® Meningitis/Encephalitis (ME) panel has reduced time to detection of several pathogens and improved diagnostic sensitivity. The objective of this study was to determine the impact on intravenous (IV) acyclovir duration of the ME panel compared to previously utilized CSF studies within a large health system with a central laboratory. A multicenter quasi-experimental cohort study of adult and pediatric patients was conducted (n = 208). The primary endpoint was duration of IV acyclovir, which was decreased (41.6 v. 30.8 hours; P < 0.01) with the ME panel. Secondary outcomes including test-turnaround time (TAT) and the impact of utilizing a central laboratory were explored. Subgroup analyses demonstrated that number of daily couriers from hospital to the central laboratory (0 versus 7 versus 3 versus 2 couriers) and hospital distance from the central laboratory (0 versus 1-10 versus 11-20 versus 21-30 miles) significantly impacted TAT (P < 0.01). While duration of IV acyclovir for the entire healthcare system was reduced, the duration at individual sites was not impacted by number of couriers or distance from the central laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193
Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00730-16 · Cited by 609
Eichinger, A., Hagen, A., Meyer-Bühn, M., & Huebner, J. (2019) · Infection · doi:10.1007/s15010-018-1212-7 · Cited by 60
Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01255-16 · Cited by 52
State-of-the-Art Microbiologic Testing for Community-Acquired Meningitis and Encephalitis
Polage, C. R., & Cohen, S. H. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00289-16 · Cited by 43
Cited by
Broadhurst, M. J., Dujari, S., Budvytiene, I., Pinsky, B. A., Gold, C. A., & Banaei, N. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00311-20 · Cited by 57
Hueth, K. D., Thompson-Leduc, P., Totev, T. I., Milbers, K., Timbrook, T. T., Kirson, N., & Hasbun, R. (2022) · Antibiotics · doi:10.3390/antibiotics11081028 · Cited by 43
Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers
Ivaska, L., Herberg, J., & Sadarangani, M. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.010 · Cited by 28
Messacar, K., Gaensbauer, J. T., Birkholz, M., Palmer, C., Todd, J. K., Tyler, K. L., & Dominguez, S. R. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115085 · Cited by 20
Rafiei, N., Subedi, S., Harris, P. N., & Paterson, D. L. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116823 · Cited by 13
Metadata
- Authors
- Evans, M., Merkel, K. G., Harder, J., & Rose, D. T.
- Venue
- Diagnostic Microbiology and Infectious Disease
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 96
- Issue
- 2
- Pages
- 114935
- ISSN
- 0732-8893 (ISSN-L)
- OpenAlex
- W2987264714
- Cited by
- 26
- References
- 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.